Vertex Pharmaceuticals Aktie

Kaufen
Verkaufen
377,30 EUR -54,70 EUR -12,66 %
395,49 USD -1,08 USD -0,27 %
nachbörslich
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 111,16 Mrd. EUR

KGV 29,28 Div. Rendite 0,00%

WKN 882807

ISIN US92532F1003

Symbol VRTX


Vertex Pharmaceuticals Aktie Analyse

16.01.07 Vertex Pharmaceuticals Neutral Susquehanna Financial
19.12.06 Vertex Pharmaceuticals halten Biotech-Report
14.12.06 Vertex Pharmaceuticals sell Banc of America Sec.
01.12.06 Vertex Pharmaceuticals market outperform Rodman & Renshaw
17.11.06 Vertex Pharmaceuticals outperform Piper Jaffray
02.11.06 Vertex Pharmaceuticals buy UBS
29.09.06 Vertex Pharmaceuticals buy Merrill Lynch
25.08.06 Vertex Pharmaceuticals buy UBS
25.08.06 Vertex Pharmaceuticals Buy UBS
24.05.06 Vertex Pharmaceuticals neutral Banc of America Sec.
02.05.06 Vertex Pharmaceuticals buy Citigroup
09.03.06 Vertex Pharmaceuticals neutral UBS
09.03.06 Vertex Pharmaceuticals buy Citigroup
03.03.06 Vertex Pharmaceuticals buy Deutsche Securities
09.02.06 Vertex Pharmaceuticals buy Citigroup
09.02.06 Vertex Pharmaceuticals peer perform Bear Stearns
09.02.06 Vertex Pharmaceuticals outperform Crédit Suisse
10.01.06 Vertex Pharmaceuticals outperform Credit Suisse First Boston
06.01.06 Vertex Pharmaceuticals outperform Credit Suisse First Boston
14.12.05 Vertex Pharmaceuticals in-line Goldman Sachs
14.12.05 Vertex Pharmaceuticals In-Line Goldman Sachs
21.11.05 Vertex Pharmaceuticals Sell Banc of America Sec.
09.11.05 Vertex Pharmaceuticals outperform Leerink Swann
09.11.05 Vertex Pharmaceuticals Outperform Leerink Swann
12.10.05 Vertex Pharmaceuticals outperform Bear Stearns
12.10.05 Vertex Pharmaceuticals Outperform Bear Stearns
12.10.05 Vertex Pharmaceuticals Outperform Bear Stearns
30.09.05 Vertex Pharmaceuticals outperform Credit Suisse First Boston
29.09.05 Vertex Pharmaceuticals overweight Prudential Financial
29.09.05 Vertex Pharmaceuticals Overweight Prudential Securities
19.08.05 Vertex Pharmaceuticals overweight JP Morgan
19.08.05 Vertex Pharmaceuticals Biotech-Report
19.08.05 Vertex Pharmaceuticals Overweight JP Morgan
11.08.05 Vertex Pharmaceuticals outperform Credit Suisse First Boston
29.07.05 Vertex Pharmaceuticals outperform Credit Suisse First Boston
14.07.05 Vertex Pharmaceuticals neutral UBS
08.07.05 Vertex Pharmaceuticals neutral Banc of America Sec.
08.07.05 Vertex Pharmaceuticals Neutral Banc of America Sec.
14.06.05 Vertex Pharmaceuticals halten Biotech-Report
23.05.05 Vertex Pharmaceuticals hold Needham & Co
23.05.05 Vertex Pharmaceuticals hold Needham & Co
20.05.05 Vertex Pharmaceuticals equal-weight Morgan Stanley
20.05.05 Vertex Pharmaceuticals equal-weight Morgan Stanley
20.05.05 Vertex Pharmaceuticals equal-weight Morgan Stanley
20.05.05 Vertex Pharmaceuticals Equal-weight Morgan Stanley
21.04.05 Vertex Pharmaceuticals Buy Needham & Co
14.04.05 Vertex Pharmaceuticals Buy Adams, Harkness & Hill
11.01.05 Vertex Pharmaceuticals Peer Perform Bear Stearns
05.01.05 Vertex Pharmaceuticals Outperform Credit Suisse First Boston